Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
2017 · Nature · 1,801 citations
https://doi.org/10.1038/nature22364
Y
Yenting Ngai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
8.8K
Citations
23
h-index
29
i10-index
Yenting Ngai is an academic researcher from Tuen Mun Hospital. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Diagnosis and Treatment & Advanced Radiotherapy Techniques. The author has an h-index of 23, co-authored 55 publications.
Papers by this author
worksFc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
2018 · Cancer Cell · 563 citations
https://doi.org/10.1016/j.ccell.2018.02.010
Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study
2014 · PLoS Biology · 251 citations
https://doi.org/10.1371/journal.pbio.1001906
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
2012 · The Lancet Oncology · 176 citations
https://doi.org/10.1016/s1470-2045(12)70412-6
A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer
2022 · Nature Cancer · 108 citations
https://doi.org/10.1038/s43018-022-00376-z
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer
2016 · International Journal of Radiation Oncology*Biology*Physics · 43 citations
https://doi.org/10.1016/j.ijrobp.2016.03.031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat